Last quarter (Q ), PLx Pharma's total revenue was $386.00K, a decrease of -94.17% from the same quarter last year. In Q, PLx Pharma's net income was $-8.50M. See PLx Pharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	$ 4.54M	$ 8.21M	$ 30.00K	$ 565.46K	$ 753.11K	$ 778.66K
Cost of Revenue	$ 4.34M	$ 4.80M	$ 0.00	-	-	-
Gross Profit	$ 202.64K	$ 3.40M	$ 30.00K	-	-	-
Operating Expense	$ 64.63M	$ 44.19M	$ 13.49M	$ 14.77M	$ 11.71M	$ 14.33M
Operating Income	$ -64.42M	$ -40.79M	$ -13.46M	$ -14.20M	$ -10.96M	$ -13.55M
Net Non Operating Interest Income Expense	$ 153.84K	$ 1.00K	$ -308.00K	$ -589.74K	$ -847.96K	$ -1.05M
Other Income Expense	$ 36.69M	$ -5.34M	$ -1.44M	$ -5.71M	$ 12.71M	$ -1.66M
Pretax Income	$ -27.58M	$ -46.13M	$ -15.21M	$ -20.50M	$ 896.48K	$ -16.27M
Tax Provision	-	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ -920.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -27.58M	$ -48.65M	$ -16.95M	$ -34.25M	$ 896.48K	$ -15.35M
Basic EPS	$ -0.72	-	$ -1.74	$ -3.84	$ 0.10	$ -2.19
Diluted EPS	$ -1.55	-	$ -1.74	$ -3.84	$ 0.10	$ -2.19
Basic Average Shares	$ 82.81M	-	$ 9.71M	$ 8.92M	$ 8.73M	$ 7.02M
Diluted Average Shares	$ 82.81M	-	$ 9.71M	$ 8.92M	$ 8.73M	$ 7.02M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	$ -1.91	-	-	-	-	-
Reported Normalized Diluted E P S	$ -2.01	-	$ -1.42	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 68.97M	$ 49.00M	$ 13.49M	$ 14.77M	$ 11.71M	$ 14.33M
Net Income From Continuing And Discontinued Operation	$ -27.58M	$ -46.13M	$ -15.21M	$ -20.50M	$ 896.48K	$ -15.35M
Normalized Income	$ -64.27M	$ -40.79M	$ -13.77M	$ -14.79M	$ -11.81M	$ -13.78M
Interest Expense	-	-	$ 307.95K	$ 589.74K	$ 1.15M	$ 1.16M
EBIT	$ -64.42M	$ -40.79M	$ -13.46M	$ -19.91M	$ 2.04M	$ -15.10M
EBITDA	$ -64.21M	$ -40.58M	$ -13.04M	$ -19.66M	$ 2.24M	$ -15.07M

Currency in USD

PLx Pharma Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing